Skip Nav Destination
Issues
January 2009
-
Cover Image
Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 0149-5992
EISSN 1935-5548
In this Issue
Editor’s Commentary
The Human Side of Diabetes Care
Diabetes Care January 2009, Vol.32, 1-2. doi:https://doi.org/10.2337/dc08-1873
Original Research
Clinical Care / Education / Nutrition / Psychosocial Research
Physical Activity May Facilitate Diabetes Prevention in Adolescents
Amy S. Thomas, MPH; Lori F. Greene, MS; Jamy D. Ard, MD; Robert A. Oster, PHD; Betty E. Darnell, MS; Barbara A. Gower, PHD
Diabetes Care January 2009, Vol.32, 9-13. doi:https://doi.org/10.2337/dc08-0780
Dipeptidyl Peptidase-4 Inhibition by Vildagliptin and the Effect on Insulin Secretion and Action in Response to Meal Ingestion in Type 2 Diabetes
Chiara Dalla Man, PHD; Gerlies Bock, MD; Paula D. Giesler, RN; Denise B. Serra, PHARMD; Monica Ligueros Saylan, MD; James E. Foley, PHD; Michael Camilleri, MD; Gianna Toffolo, PHD; Claudio Cobelli, PHD; Robert A. Rizza, MD; Adrian Vella, MD
Diabetes Care January 2009, Vol.32, 14-18. doi:https://doi.org/10.2337/dc08-1512
Diabetic Patients’ Medication Underuse, Illness Outcomes, and Beliefs About Antihyperglycemic and Antihypertensive Treatments
Diabetes Care January 2009, Vol.32, 19-24. doi:https://doi.org/10.2337/dc08-1533
Factors Associated With Intensification of Oral Diabetes Medications in Primary Care Provider-Patient Dyads: A Cohort Study
Shari Danielle Bolen, MD, MPH; Eric Bricker, MD, MPH; T. Alafia Samuels, MD, MPH, PHD; Hsin-Chieh Yeh, PHD; Spyridon S. Marinopoulos, MD, MBA; Maura McGuire, MD; Marcela Abuid, MD; Frederick L. Brancati, MD, MHS
Diabetes Care January 2009, Vol.32, 25-31. doi:https://doi.org/10.2337/dc08-1297
Comparison of Once- Versus Twice-Daily Administration of Insulin Detemir, Used With Mealtime Insulin Aspart, in Basal-Bolus Therapy for Type 1 Diabetes: Assessment of Detemir Administration in a Progressive Treat-To-Target Trial (ADAPT)
Jean-Pierre Le Floch, MD; Marc Lévy, MD; Helen Mosnier-Pudar, MD; Frank Nobels, MD; Sylvie Laroche, MD; Sophie Gonbert, MD, PHD; Eveline Eschwege, MD, PHD; Pierre Fontaine, MD; The Assessment of Detemir Administration in a Progressive Treat-to-Target Trial (ADAPT) Study Group
Diabetes Care January 2009, Vol.32, 32-37. doi:https://doi.org/10.2337/dc08-0332
Improved Pregnancy Outcome in Type 1 Diabetic Women With Microalbuminuria or Diabetic Nephropathy: Effect of intensified antihypertensive therapy?
Diabetes Care January 2009, Vol.32, 38-44. doi:https://doi.org/10.2337/dc08-1526
Effect of a Successful Intensive Lifestyle Program on Insulin Sensitivity and Glucose Tolerance in Obese Youth
Melissa Shaw; Mary Savoye, RD, CDE; Anna Cali, MD; James Dziura, PHD; William V. Tamborlane, MD; Sonia Caprio, MD
Diabetes Care January 2009, Vol.32, 45-47. doi:https://doi.org/10.2337/dc08-0808
Biophysical Correlates of Cognition Among Depressed and Nondepressed Type 2 Diabetic Patients
Diabetes Care January 2009, Vol.32, 48-50. doi:https://doi.org/10.2337/dc08-0899
Diabetes Medication Satisfaction Tool: A focus on treatment regimens
Roger T. Anderson, PHD; Cynthia J. Girman, DRPH; Manjiri D. Pawaskar, PHD; Fabian T. Camacho, MS; Jorge Calles, MD; William S. Kelly, MD; Carla DeMuro, MS; Rajesh Balkrishnan, PHD
Diabetes Care January 2009, Vol.32, 51-53. doi:https://doi.org/10.2337/dc08-0856
Clinical and Behavioral Correlates of Achieving and Maintaining Glycemic Targets in an Underserved Population With Type 2 Diabetes
Diabetes Care January 2009, Vol.32, 54-56. doi:https://doi.org/10.2337/dc08-1234
Epidemiology / Health Services Research
Prevalence and Control of Diabetes and Impaired Fasting Glucose in New York City
Lorna E. Thorpe, PHD; Ushma D. Upadhyay, PHD; Shadi Chamany, MD; Renu Garg, MPH; Jenna Mandel-Ricci, MPA; Scott Kellerman, MD; Diana K. Berger, MD; Thomas R. Frieden, MD; Charon Gwynn, PHD
Diabetes Care January 2009, Vol.32, 57-62. doi:https://doi.org/10.2337/dc08-0727
Effect of Parental Type 2 Diabetes on Offspring With Type 1 Diabetes
Lena M. Thorn, MD; Carol Forsblom, MD, DMSC; Johan Wadén, MD; Jenny Söderlund, MSC; Milla Rosengård-Bärlund, MD; Markku Saraheimo, MD; Outi Heikkilä, MD; Kustaa Hietala, MD; Kim Pettersson-Fernholm, MD, DMSC; Jorma Ilonen, MD, DMSC; Per-Henrik Groop, MD, DMSC; on behalf of the FinnDiane Study Group
Diabetes Care January 2009, Vol.32, 63-68. doi:https://doi.org/10.2337/dc08-0472
Population-Based Study on the Prevalence and Risk Factors of Orthostatic Hypotension in Subjects With Pre-Diabetes and Diabetes
Jin-Shang Wu, MD, MS; Yi-Ching Yang, MD, MPH; Feng-Hwa Lu, MD, MS; Chih-Hsing Wu, MD; Ru-Hsueh Wang, MD; Chih-Jen Chang, MD
Diabetes Care January 2009, Vol.32, 69-74. doi:https://doi.org/10.2337/dc08-1389
Performance of Comorbidity, Risk Adjustment, and Functional Status Measures in Expenditure Prediction for Patients With Diabetes
Diabetes Care January 2009, Vol.32, 75-80. doi:https://doi.org/10.2337/dc08-1099
Quality of Care for Patients With Type 2 Diabetes in Primary Care in Norway Is Improving: Results of cross-sectional surveys of 33 general practices in 1995 and 2005
John Graham Cooper, MBBS, MRCP; Tor Claudi, MD; Anne Karen Jenum, PHD; Geir Thue, PHD; Marie Fjelde Hausken, RN; Wibeche Ingskog, RN; Sverre Sandberg, PHD
Diabetes Care January 2009, Vol.32, 81-83. doi:https://doi.org/10.2337/dc08-0605
Emerging Treatments and Technologies
Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes: The LEAD (Liraglutide Effect and Action in Diabetes)-2 study
Michael Nauck, MD, PHD; Anders Frid, MD; Kjeld Hermansen, MD; Nalini S. Shah, MD; Tsvetalina Tankova, MD; Ismail H. Mitha, MD; Milan Zdravkovic, MD, PHD; Maria Düring, PHD; David R. Matthews, MD; for the LEAD-2 Study Group
Diabetes Care January 2009, Vol.32, 84-90. doi:https://doi.org/10.2337/dc08-1355
Effect of Protein Kinase Cβ Inhibition on Renal Hemodynamic Function and Urinary Biomarkers in Humans With Type 1 Diabetes: A Pilot Study
David Z.I. Cherney, MD, CM, PHD; Ana Konvalinka, MD; Bernard Zinman, MD; Eleftherios P. Diamandis, MD, PHD; Anton Soosaipillai, BSC; Heather Reich, MD, CM, PHD; Joanne Lorraine, MD; Vesta Lai, RN; James W. Scholey, MD; Judith A. Miller, MD, MSC, MHSC
Diabetes Care January 2009, Vol.32, 91-93. doi:https://doi.org/10.2337/dc08-1609
Pathophysiology / Complications
Weight Gain in Early Life Predicts Risk of Islet Autoimmunity in Children With a First-Degree Relative With Type 1 Diabetes
Jennifer J. Couper, MD; Sarah Beresford, DIPN; Craig Hirte; Peter A. Baghurst, PHD; Angie Pollard; Brian D. Tait, PHD; Leonard C. Harrison, PHD; Peter G. Colman, PHD
Diabetes Care January 2009, Vol.32, 94-99. doi:https://doi.org/10.2337/dc08-0821
In Vivo Insulin Sensitivity and Secretion in Obese Youth: What are the differences between normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes?
Diabetes Care January 2009, Vol.32, 100-105. doi:https://doi.org/10.2337/dc08-1030
Quantitative Assessment of Early Diabetic Retinopathy Using Fractal Analysis
Ning Cheung, MBBS; Kim C. Donaghue, MBBS, PHD; Gerald Liew, MBBS, MMED; Sophie L. Rogers, MEPI; Jie Jin Wang, PHD; Shueh-Wen Lim, BMEDSCI; Alicia J. Jenkins, MBBS, MD; Wynne Hsu, PHD; Mong Li Lee, PHD; Tien Y. Wong, MBBS, PHD
Diabetes Care January 2009, Vol.32, 106-110. doi:https://doi.org/10.2337/dc08-1233
Clinical Heterogeneity in Patients With FOXP3 Mutations Presenting With Permanent Neonatal Diabetes
Oscar Rubio-Cabezas, MD; Jayne A.L. Minton, PHD; Richard Caswell, PHD; Julian P. Shield, MD; Dorothee Deiss, MD; Zdenek Sumnik, MD, PHD; Amely Cayssials, MD; Mathias Herr, MD; Anja Loew, MD; Vaughan Lewis, MD; Sian Ellard, PHD, MRCPATH; Andrew T. Hattersley, DM, FRCP
Diabetes Care January 2009, Vol.32, 111-116. doi:https://doi.org/10.2337/dc08-1188
Increased Matrix Metalloproteinase-9 Predicts Poor Wound Healing in Diabetic Foot Ulcers
Yu Liu, MD; Danqing Min, PHD; Thyra Bolton; Vanessa Nubé; Stephen M. Twigg, PHD, MD; Dennis K. Yue, PHD, MD; Susan V. McLennan, PHD
Diabetes Care January 2009, Vol.32, 117-119. doi:https://doi.org/10.2337/dc08-0763
Insulin Gene Mutations as Cause of Diabetes in Children Negative for Five Type 1 Diabetes Autoantibodies
Riccardo Bonfanti, MD; Carlo Colombo; Valentina Nocerino; Ornella Massa, PHD; Vito Lampasona, PHD; Dario Iafusco, MD; Matteo Viscardi, MD; Giuseppe Chiumello, MD; Franco Meschi, MD; Fabrizio Barbetti, MD, PHD
Diabetes Care January 2009, Vol.32, 123-125. doi:https://doi.org/10.2337/dc08-0783
Serum Levels of the Adipokine FGF21 Depend on Renal Function
Sebastian Stein, MS; Anette Bachmann, MD; Ulrike Lössner; Jürgen Kratzsch, PHD; Matthias Blüher, MD; Michael Stumvoll, MD; Mathias Fasshauer, MD
Diabetes Care January 2009, Vol.32, 126-128. doi:https://doi.org/10.2337/dc08-1054
Ex Vivo and In Vivo Regulation of Lipocalin-2, a Novel Adipokine, by Insulin
Bee K. Tan, MBBS, PHD; Raghu Adya, MBBS, MSC; Xiaoye Shan, BSC; Farhatullah Syed, MSC, PHD; Krzysztof C. Lewandowski, MRCP, MD; John P. O'Hare, FRCP, MD; Harpal S. Randeva, FRCP, MD, PHD
Diabetes Care January 2009, Vol.32, 129-131. doi:https://doi.org/10.2337/dc08-1236
Circulating Levels of Adipocyte and Epidermal Fatty Acid–Binding Proteins in Relation to Nephropathy Staging and Macrovascular Complications in Type 2 Diabetic Patients
Dennis C.Y. Yeung, BSC; Aimin Xu, PHD; Annette W.K. Tso, MD; W.S. Chow, MD; Nelson M.S. Wat, MD; Carol H.Y. Fong, BSC; Sidney Tam, MD; Pak C. Sham, MD; Karen S.L. Lam, MD
Diabetes Care January 2009, Vol.32, 132-134. doi:https://doi.org/10.2337/dc08-1333
Allopurinol and Nitric Oxide Activity in the Cerebral Circulation of Those With Diabetes: A randomized trial
Jesse Dawson, MRCP; Terry Quinn, MRCP; Craig Harrow, MRCP; Kennedy R. Lees, MD, FRCP; Christopher J. Weir, PHD; Stephen J. Cleland, PHD, FRCP; Matthew R. Walters, MD, FRCP
Diabetes Care January 2009, Vol.32, 135-137. doi:https://doi.org/10.2337/dc08-1179
Nitric Oxide Bioavailability and Its Potential Relevance to the Variation in Susceptibility to the Renal and Vascular Complications in Patients With Type 2 Diabetes
Kenneth A. Earle, MD; Diane Harry, RGN; Mitra Madhavi, MBBS; Karima Zitouni, PHD; Jeffrey Barron, PHD
Diabetes Care January 2009, Vol.32, 138-140. doi:https://doi.org/10.2337/dc08-0885
Cardiovascular and Metabolic Risk
Blood Pressure and Fasting Plasma Glucose Rather Than Metabolic Syndrome Predict Coronary Artery Calcium Progression: The Rancho Bernardo Study
Caroline K. Kramer, MD; Denise von Mühlen, PHD, MD; Jorge L. Gross, PHD, MD; Gail A. Laughlin, PHD; Elizabeth Barrett-Connor, MD
Diabetes Care January 2009, Vol.32, 141-146. doi:https://doi.org/10.2337/dc08-1360
Serum Adipocyte Fatty Acid–Binding Protein Levels Are Associated With Nonalcoholic Fatty Liver Disease in Type 2 Diabetic Patients
Jang Hyun Koh, MD; Young Goo Shin, MD, PHD; Soo Min Nam, MD; Mi Young Lee, MD; Choon Hee Chung, MD, PHD; Jang Yel Shin, MD
Diabetes Care January 2009, Vol.32, 147-152. doi:https://doi.org/10.2337/dc08-1379
Metabolic Syndrome and All-Cause and Cardiovascular Mortality in an Italian Elderly Population: The Progetto Veneto Anziani (Pro.V.A.) Study
Sabina Zambon, MD; Silvia Zanoni, MD; Giovanna Romanato, MD; Maria Chiara Corti, MD; Marianna Noale, MSC; Leonardo Sartori, MD; Estella Musacchio, PHD; Giovannella Baggio, MD; Gaetano Crepaldi, MD; Enzo Manzato, MD
Diabetes Care January 2009, Vol.32, 153-159. doi:https://doi.org/10.2337/dc08-1256
Metabolic Syndrome and Autoimmune Diabetes: Action LADA 3
Mohammed I. Hawa, BSC; Charles Thivolet, MD; Didac Mauricio, MD; Irene Alemanno, MD; Elisa Cipponeri, MD; David Collier, MD; Steven Hunter, MD; Raffaella Buzzetti, MD; Alberto de Leiva, MD; Paolo Pozzilli, MD; Richard David G. Leslie, MD; on behalf of the Action LADA Group
Diabetes Care January 2009, Vol.32, 160-164. doi:https://doi.org/10.2337/dc08-1419
Pitfalls in the Measurement of the Nocturnal Blood Pressure Dip in Adolescents with Type 1 Diabetes
Diabetes Care January 2009, Vol.32, 165-168. doi:https://doi.org/10.2337/dc08-1319
Metabolic Syndrome and Risk for Incident Alzheimer's Disease or Vascular Dementia: The Three-City Study
Christelle Raffaitin, MD; Henri Gin, MD, PHD; Jean-Philippe Empana, MD, PHD; Catherine Helmer, MD, PHD; Claudine Berr, MD, PHD; Christophe Tzourio, MD, PHD; Florence Portet, MD; Jean-François Dartigues, MD, PHD; Annick Alpérovitch, MD, PHD; Pascale Barberger-Gateau, MD, PHD
Diabetes Care January 2009, Vol.32, 169-174. doi:https://doi.org/10.2337/dc08-0272
Cardiovascular Risk Factors Among Youth With and Without Type 2 Diabetes: Differences and possible mechanisms
Nancy A. West, PHD; Richard F. Hamman, MD; Elizabeth J. Mayer-Davis, PHD; Ralph B. D'Agostino, Jr., PHD; Santica M. Marcovina, PHD; Angela D. Liese, PHD; Philip S. Zeitler, MD; Stephen R. Daniels, MD; Dana Dabelea, MD
Diabetes Care January 2009, Vol.32, 175-180. doi:https://doi.org/10.2337/dc08-1442
Noninvasive Evaluation of Neural Impairment in Subjects With Impaired Glucose Tolerance
Zsuzsanna Putz, MD; Ádám G Tabák, MD, PHD; Nelli Tóth, MD; Ildikó Istenes, MD; Nóra Németh; Rajiv A. Gandhi, MD; Zsolt Hermányi, MD; Katalin Keresztes, MD, PHD; György Jermendy, MD, PHD, DSC; Solomon Tesfaye, MD, FRCP; Péter Kempler, MD, PHD, DSC
Diabetes Care January 2009, Vol.32, 181-183. doi:https://doi.org/10.2337/dc08-1406
Plasma Apolipoprotein CI and CIII Levels Are Associated With Increased Plasma Triglyceride Levels and Decreased Fat Mass in Men With the Metabolic Syndrome
Rachel L.M. van der Ham, MD; Reza Alizadeh Dehnavi, MD; Jimmy F.P. Berbée, PHD; Hein Putter, PHD; Albert de Roos, MD, PHD; Johannes A. Romijn, MD, PHD; Patrick C.N. Rensen, PHD; Jouke T. Tamsma, MD, PHD
Diabetes Care January 2009, Vol.32, 184-186. doi:https://doi.org/10.2337/dc08-1330
Reviews / Commentaries / ADA Statements
Position Statement
Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials: A position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association
Jay S. Skyler, MD, MACP; Richard Bergenstal, MD; Robert O. Bonow, MD, MACC, FAHA; John Buse, MD, PHD; Prakash Deedwania, MD, FACC, FAHA; Edwin A.M. Gale, MD; Barbara V. Howard, PHD; M. Sue Kirkman, MD; Mikhail Kosiborod, MD, FACC; Peter Reaven, MD; Robert S. Sherwin, MD
Diabetes Care January 2009, Vol.32, 187-192. doi:https://doi.org/10.2337/dc08-9026
Consensus Statement
Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A consensus statement of the American Diabetes Association and the European Association for the Study of Diabetes
David M. Nathan, MD; John B. Buse, MD, PHD; Mayer B. Davidson, MD; Ele Ferrannini, MD; Rury R. Holman, FRCP; Robert Sherwin, MD; Bernard Zinman, MD
Diabetes Care January 2009, Vol.32, 193-203. doi:https://doi.org/10.2337/dc08-9025
Perspectives on the News
Type 1 Diabetes and Hypoglycemia
Diabetes Care January 2009, Vol.32, e1-e4. doi:https://doi.org/10.2337/dc09-zb01
Editorials
New York City Health and Nutrition Examination Survey: A model for urban health surveillance
Diabetes Care January 2009, Vol.32, 204-205. doi:https://doi.org/10.2337/dc08-1807
Errata
Online Letters: Comments and Responses
Translating the A1C Assay Into Estimated Average Glucose Values: Response to Nathan et al.
Diabetes Care January 2009, Vol.32, e10. doi:https://doi.org/10.2337/dc08-1214
Translating the A1C Assay Into Estimated Average Glucose Values: Response to Nathan et al.
Diabetes Care January 2009, Vol.32, e11. doi:https://doi.org/10.2337/dc08-1524
Response to Rodríguez-Segade et al. and Leslie and Kilpatrick
Diabetes Care January 2009, Vol.32, e12. doi:https://doi.org/10.2337/dc08-1752
Online Letters: Observations
Osteoprotegerin Levels in Women With Prior Gestational Diabetes Mellitus
Eszter Madarász, MD; Gyula Tamás, MD, PHD; Ádám Gy. Tabák, MD, PHD; Gábor Speer, MD, PHD; Péter Lakatos, MD, PHD, DSC; Zsuzsa Kerényi, MD, PHD
Diabetes Care January 2009, Vol.32, e5. doi:https://doi.org/10.2337/dc08-1628
Serum Visceral Adipose Tissue–Derived Serine Protease Inhibitor Concentrations in Human Obesity and Polycystic Ovary Syndrome
Diabetes Care January 2009, Vol.32, e6. doi:https://doi.org/10.2337/dc08-1690
Long-Standing Sulfonylurea Therapy After Pubertal Relapse of Neonatal Diabetes in a Case of Uniparental Paternal Isodisomy of Chromosome 6
Diabetes Care January 2009, Vol.32, e9. doi:https://doi.org/10.2337/dc08-1813
